Her work demonstrated the effectiveness of these platforms in testing clinical serum specimens to accurately distinguish PCR-positive patients. Current Research at GeneOne Life Science

: Her research includes the design of highly sensitive, microfluidic magneto immunosensors aimed at rapid measurement of viral proteins in serum, advancing the field of intelligent health management [2].

is an emerging bioengineering researcher and scientist whose top contributions center on SARS-CoV-2 viral proteins, diagnostics, and advanced therapeutic platforms . Having conducted high-impact molecular research at institutions like the University of Pennsylvania and the GeneOne Life Science network, Irudayaraj has become a notable voice in translational virology and global pandemic preparedness.

: Irudayaraj's contributions extend to evaluating the performance of rapid antigen detection (RAD) tests and comparing them against traditional RT-PCR methods to improve diagnostic accuracy during public health emergencies. Academic and Social Presence

Prior to her leadership at AstraZeneca, she held several senior-level positions at , where she played a critical role in clinical operations and development, particularly in the oncology and immunology sectors.

In summary, the name "Pratiba Irudayaraj" is not limited to a single narrative. It represents a dynamic fusion of scientific intellect, artistic talent, and human compassion. From the high-tech laboratories of Seoul contributing to pandemic research, to the vibrant wedding salons of India making brides look their best, and from the academic halls of Pennsylvania to a high school art club in Massachusetts, the impact is far-reaching.